Biocon

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Map view:

Zoom: 100%

More settings

Connection length 100% Label size 100% Node size 100% Line width 100% Label width 100%

Export map as:

Biocon topic overview

The analysis highlights History, Art, Companies and Products as prominent areas in the source structure around Biocon.

Related topics: 70
Source areas: 5
Connected nodes: 75
Extracted relationships: 242
Concept neighborhoods: 20
Bridge connections: 75

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

History · 25 topics

Overview · 24 topics

Strategic partnerships · 11 topics

Subsidiaries · 9 topics

Facilities · 1 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

Founded: 1978 (48 years ago) (1978)
Industry: Biopharmaceutical · Biotechnology
Headquarters: Bengaluru, Karnataka, India
Founder: Kiran Mazumdar-Shaw
ISIN: INE376G01013
Key people: Kiran Mazumdar-Shaw (executive chairperson) · Shreehas P Tambe (CEO & Managing Director, Biocon Limited)

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How Biocon connects Entity context

The extracted context around Biocon shows recurring relationship patterns in the source. For example, Biocon → Abraxis BioScience, Amylin Pharmaceuticals, As, Australia, BVX, BVX-20, Canada, CDI, Clostridioides, EU, European, European Free Trade Association, GCSF, Granulocyte Colony-Stimulating Factor, IATRICa, In, In January, Inc, Japan, New Zealand Another extracted example is Biocon → April, As, Biocon Biologics India Limited, Biocon Biologics Limited, Biocon Group, Biocon Limited, CEO, Chief Executive Officer, Chief Financial Officer, Christiane Hamacher, December, Effective, Hamacher, In, July, Kedar Upadhye, Managing Director, Managing Director Arun Chandavarkar, March, Mazumdar-Shaw. Use these groups to spot repeated connection types before inspecting the individual relationships.

Top relations

related to Strategic partnerships · 31

Biocon → Abraxis BioScience, Amylin Pharmaceuticals, As, Australia, BVX, BVX-20, Canada, CDI, Clostridioides, EU, European, European Free Trade Association, GCSF, Granulocyte Colony-Stimulating Factor, IATRICa, In, In January, Inc, Japan, New Zealand

related to Corporate governance · 24

Biocon → April, As, Biocon Biologics India Limited, Biocon Biologics Limited, Biocon Group, Biocon Limited, CEO, Chief Executive Officer, Chief Financial Officer, Christiane Hamacher, December, Effective, Hamacher, In, July, Kedar Upadhye, Managing Director, Managing Director Arun Chandavarkar, March, Mazumdar-Shaw

related to Biosimilars · 23

Biocon → Another, Bicocon, Biocon Biologics, Biocon's, Biosimilars, European Commission's, Herceptin, In, In December, India, Indian, Japan, Much, Mylan, Mylan-Biocon's, Sanofi's Lantus, Semglee, Serum Institute, The, These

related to Syngene International Ltd · 23

Biocon → Amgen, API, Bangalore, Bristol Myers Squibb, CDMO, Clinigene International Limited, Established, GlaxoSmithKline, Hyderabad, In, In July, In September, Librela, Mangalore, Phase I-IV, Since, Syngene, Syngene International, Syngene International Limited, Syngene's

related to Global market · 20

Biocon → American, American Food, Amgen, Asian, AxiCorp GmbH, Bangalone, Bengaluru, Biocon Biologics, Biocon's, Bristol Myers Squibb, Drug Administration, During, European, European Commission, German, In, Malaysia, Mylan, Regulatory, The

related to Integration of Biocon Biologics · 19

Biocon → Activ Pine LLP, BBL, Biocon Biologics Limited, December, EY, II, IPO, It, January, Mylan Inc, On, QIP, Serum Institute Life Sciences, Tata Capital Growth Fund, The, To, Under, US, Viatris

related to Further reading · 18

Biocon → Ananth, Arnoud, Bhardwaj, Biocon India, Biocon Limited, Chepuri, De Meyer, Harvard Business Publishing, Harvard Business School Case, INSEAD, INSEAD Case Study, Krishna, October, Palepu, Reference, Retrieved, Study, The Case Centre

related to Biocon Biologics · 13

Biocon → Biocon Biologics, Biocon's, COVID-19, Founded, In, In May, India, Pune, Serum Institute, Serum Institute's, These, US, Viatris

related to Other subsidiaries · 12

Biocon → Abu Dhabi, AxiCorp GmbH, BBPL, Biocon Biopharmaceuticals Pvt, Biofusion Therapeutics Limited, CIMAB, Cuban, German, In, Ltd, NeoBiocon FZ LLC, The

related to history · 11

Biocon → Biocon Biochemicals Ltd, Biocon India Private Limited, Europe, Iisinglass, In, India-based, Indian, Irish, Mazumdar-Shaw, The, US

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

biologics market limited company biosimilar syngene subsidiary international biosimilars indian biocon's us india research pharmaceutical viatris products drug sold also

Biocon relationships Subject–Predicate–Object triples

TTTA extracted 242 structured relationships around Biocon. Examples in this analysis include Biocon → Founded → 1978 (48 years ago) (1978) and Biocon → Founder → Kiran Mazumdar-Shaw. The table shows each extracted connection, where it came from and its confidence.

Subject	Predicate	Object	Confidence	Src
Biocon	Founded	1978 (48 years ago) (1978)	1.00	infobox
Biocon	Founder	Kiran Mazumdar-Shaw	1.00	infobox
Biocon	Headquarters	Bengaluru, Karnataka, India	1.00	infobox
Biocon	Industry	Biopharmaceutical	1.00	infobox
Biocon	Industry	Biotechnology	1.00	infobox
Biocon	ISIN	INE376G01013	1.00	infobox
Biocon	Key people	Kiran Mazumdar-Shaw (executive chairperson)	1.00	infobox
Biocon	Key people	Shreehas P Tambe (CEO & Managing Director, Biocon Limited)	1.00	infobox
Biocon	Net income	₹1,013 crore (US$110 million) (2025)	1.00	infobox
Biocon	Number of employees	16,545 (March 2023)	1.00	infobox
Biocon	Operating income	₹4,374 crore (US$450 million) (2025)	1.00	infobox
Biocon	Products	Biologics	1.00	infobox
Biocon	Products	Small molecules	1.00	infobox
Biocon	Products	Branded formulations	1.00	infobox
Biocon	Products	Research services	1.00	infobox
Biocon	Revenue	₹16,470 crore (US$1.7 billion) (2025)	1.00	infobox
Biocon	Subsidiaries	Biocon Biologics	1.00	infobox
Biocon	Subsidiaries	Syngene International	1.00	infobox
Biocon	Total assets	₹58,797 crore (US$6.1 billion) (2025)	1.00	infobox
Biocon	Total equity	₹27,712 crore (US$2.9 billion) (2025)	1.00	infobox
Biocon	Traded as	BSE: 532523 NSE: BIOCON	1.00	infobox
Biocon	Type	Public	1.00	infobox
Biocon	Website	www.biocon.com	1.00	infobox

Related concept clusters Concept neighborhoods

The concept neighborhoods around Biocon bring nearby vocabulary together. In this analysis, examples include Biologics, Limited and Subsidiary. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

Biocon
- Biologics
- Limited
- Subsidiary
- Company
- Market
- Us
- India
- Pharmaceutical
- International
- Biosimilar
- Agreement
- Billion
biocon
- Biologics
- Limited
- Subsidiary
- Company
- Market
- Us
- India
- Pharmaceutical
- International
- Biosimilar
- Agreement
- Billion
bengaluru
- Biopharmaceutical
- Global
- Research
- Generic
- Ltd
- Mazumdar-shaw
- Novel
- Limited
- Market
- Million
- Products
- Billion
biopharmaceutical
- Ltd
- Mazumdar-shaw
- Novel
- Limited
- Company
- Million
- Products
- Agreement
- Billion
- Global
- India
- Indian
quest international
- Syngene
- Limited
- Research
- Ltd
- Novel
- Development
- Subsidiary
- Global
- Pharmaceutical
- Market
- Mazumdar-shaw
- Million
generic
- Pharmaceutical
- Ltd
- Mazumdar-shaw
- Novel
- Sold
- Agreement
- European
- Global
- Viatris
- Biologics
- Research
- International
kiran mazumdar-shaw
- India
- Limited
- Novel
- Million
- Products
- Sold
- Billion
- Global
- Biologics
- Pharmaceutical
- Research
- Biosimilars
biosimilar insulins
- Glargine
- Market
- European
- Viatris
- Biocon's
- Indian
- Subsidiary
- Antibodies
- Novel
- Products
- Sold
- Agreement

Connections between topic areas Semantic bridges

For Biocon, one of the stronger structural bridges in this analysis connects Biocon with History. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3

Biocon — History · splits 50 ⟂ 26

Biocon — Overview · splits 51 ⟂ 25

Biocon — Strategic partnerships · splits 64 ⟂ 12

Biocon — Subsidiaries · splits 66 ⟂ 10

Map overview Semantic statistics

Biocon

Nodes76

Edges75

Triples242

Avg. degree1.97

Density0.026316

Components1

Source & methodology

TTTA analyzes the structure around Biocon to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Art, Companies & Products, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Biocon · EN edition · Analysis: TopicsToTalkAbout